Prospective, randomized, blinded, comparative study between botulinum toxin and topical capsaicin in the treatment of postmastectomy syndrome. Pilot study

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513609-29-01

Acronym

SPM 2024

Enrollment

Registered

2024-09-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmastectomy Syndrome

Brief summary

Pain assessment: Recording of pain intensity using a visual analogue scale (VAS), Characterization of the predominant pain perception: burning, stabbing pain, sensation of pressure or numbness.

Detailed description

Recording of side effects, Recording of the degree of patient satisfaction, Recording of concomitant analgesic medications

Interventions

DRUGXEOMIN 100 unidades polvo para solución inyectable

DRUGQutenza 179 mg cutaneous patch

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Pain assessment: Recording of pain intensity using a visual analogue scale (VAS), Characterization of the predominant pain perception: burning, stabbing pain, sensation of pressure or numbness.	—

Secondary

Measure	Time frame
Recording of side effects, Recording of the degree of patient satisfaction, Recording of concomitant analgesic medications	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026